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Analysis of effectiveness
The analysis of the clinical study was based on intention to treat. The primary outcomes assessed were: application; drying and removal times; user satisfaction; the importance attached to flammability; the time taken to apply the product; the time for the product to dry; the time taken to prepare the patient before applying the product; patient comfort after removing the product; and product odour.
The authors reported baseline characteristics.
Effectiveness results
User satisfaction was measured using a 5-point Likert scale to assess the following characteristics: ease of application; drying speed; ease of removal; adaptability of the product to different surgical sites; fireproof characteristics; the ability of the product to conform to the contours of leg; and even application to the skin.
The application, drying and removal times for the different products were presented as the mean time (in seconds) plus or minus the standard deviation (SD):
Povidone: application 228.0 (SD=42.6); drying 117.8 (SD=54.9); removal 54.4 (SD=25.1).
Duraprep: application 82.8 (SD=20.2); drying 86.0 (SD=37.3); removal 80.9 (SD=32.5).
Prevail: application 42.2 (SD=11.6); drying 63.8 (SD=33.3); removal 42.4 (SD=21.9).
LiquiDrape: application 54.1 (SD=21.4); drying 92.5 (SD=60.8); removal 74.0 (SD=45.8).
Statistical significance (p<0.05) was reached for all application time comparisons except for Prevail versus LiquiDrape. In terms of drying times, the only statistically-significant difference was for Prevail versus LiquiDrape. In terms of removal times, there were statistically-significant differences for Povidone versus Duraprep, Prevail versus Duraprep and Prevail versus LiquiDrape.
The overall ranking of the products, in terms of the mean score, was 1.8 (SD=1.01) for Povidone, 2.1 (SD=0.83) for Prevail, 3.8 (SD=1.0) for LiquiDrape, and 3.1 (SD=1.05) for Duraprep.
The results of user satisfaction were summarised as follows:
Povidone ranked highest for east of application (mean 1.84, SD=0.69), ease of removal (mean 2.16, SD=0.69), adaptability (mean 2.12, SD=0.53) and fireproof characteristics (mean 1.84, SD=0.69). Statistical significance was only reached for Povidone when compared to Duraprep and LiquiDrape in terms of adaptability.
The product characteristics deemed to be the most important were flammability (mean 1.5, SD=1.08) and application time (mean 2.8, SD=1.38). Patient comfort was ranked 3.6 (SD=1.63).
